Brittany Bradrick - 12 Jan 2022 Form 3 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role: Director
Signature: /s/ Gerald T. Proehl, Attorney-in Fact
Issuer symbol: DRMA
Transactions as of: 12 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 14 Jan 2022, 16:07:40 UTC
Next filing: 08 Apr 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24. Power of Attorney